Academic History

Inhye Ahn, MD, is a hematologist and medical oncologist at Dana-Farber Cancer Institute, Boston, MA, where she is associate director of the chronic lymphocytic leukemia (CLL) Center and works as a senior physician. Dr Ahn is also an assistant professor of medicine at Harvard Medical School, Boston, MA.

Dr Ahn received her MD from the Catholic University of Korea, Seoul, South Korea, and completed her residency at The Methodist Hospital in Houston, TX, followed by a fellowship in hematology and medical oncology at the National Institutes of Health (NIH).

Speaking on CLL, BTK inhibitors, targeted therapies, and translational research

Dr Ahn specializes in the treatment of CLL and B-cell malignancies, with a strong focus on translational and clinical research aimed at improving outcomes for patients. Her specific interests include BTK inhibitors, BCL-2 inhibitors, treatment resistance, Richter’s transformation, measurable residual disease, and the integration of translational biomarkers into clinical care.